Source:http://linkedlifedata.com/resource/pubmed/id/17283226
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-2-6
|
pubmed:abstractText |
Thyroid hormone (T(3)) is a key regulator of fetal organ maturation. Premature elevations of thyroid hormone may lead to a 'mature' cardio-phenotype. Thyroid hormone will stimulate maturation of ovine fetal cardiomyocytes in culture by decreasing their proliferative capacity. Group 1 fetal cardiomyocytes (approximately 135 days gestation) were incubated with T3 (1.5, 3, 10, and 100 nM) and bromodeoxyuridine (BrdU; 10 microM) for 24 and 48 h. Group 2 cardiomyocytes were cultured with T3 alone for later protein analysis of cell cycle regulators. At all concentrations, T3 decreased BrdU uptake fourfold in serum media (P<0.001 versus serum, n=5). Following serum-free (SF) T3 treatment, BrdU uptake was inhibited when compared with serum (P<0.001 versus serum, n=5). p21 expression increased threefold (P<0.05 versus serum free, n=4) and cyclin D1 expression decreased twofold (P<0.05 versus serum, n=4) in T3-treated cardiomyocytes. (1) T3 inhibits fetal cardiomyocyte proliferation, while (2) p21 protein levels increase, and (3) cyclin D1 levels decrease. Thus, T3 may be a potent regulator of cardiomyocyte proliferation and maturation in the late gestation fetus.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Bromodeoxyuridine,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin D1,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/Triiodothyronine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-0795
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
192
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
R1-8
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:17283226-Animals,
pubmed-meshheading:17283226-Biological Markers,
pubmed-meshheading:17283226-Bromodeoxyuridine,
pubmed-meshheading:17283226-Cell Proliferation,
pubmed-meshheading:17283226-Cells, Cultured,
pubmed-meshheading:17283226-Cyclin D1,
pubmed-meshheading:17283226-Cyclin-Dependent Kinase Inhibitor p21,
pubmed-meshheading:17283226-Depression, Chemical,
pubmed-meshheading:17283226-Female,
pubmed-meshheading:17283226-Heart,
pubmed-meshheading:17283226-Immunohistochemistry,
pubmed-meshheading:17283226-Myocytes, Cardiac,
pubmed-meshheading:17283226-Pregnancy,
pubmed-meshheading:17283226-Sheep,
pubmed-meshheading:17283226-Triiodothyronine
|
pubmed:year |
2007
|
pubmed:articleTitle |
Thyroid hormone inhibits proliferation of fetal cardiac myocytes in vitro.
|
pubmed:affiliation |
Heart Research Center, Oregon Health and Science University, Portland, Oregon 97239-3098, USA. chatterg@ohsu.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|